OptimizeRx Corporation — Quarterly Financial Statistics (NASDAQ:OPRX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 1.79 M198 K3.86 M4.56 M3.2 M 11.82 M Cash from investing activities 92 K120 K84 K44 K10 K 258 K Cash from financing activities 532 K2.82 M587 K4.5 M258 K 8.17 M Free cash flow 1.7 M78 K3.78 M4.52 M3.19 M 11.57 M

Haberler

Intuit (INTU) Q2 Earnings and Revenues Top Estimates

Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength?

OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story

Jim Lang élu au conseil d’administration de Halozyme

New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More

OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript

Earnings call transcript: OptimizeRx’s Q3 2025 Earnings Beat Expectations

OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates

OPTIMIZERx earnings beat by $0.16, revenue topped estimates

Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday

L’objectif de prix d’OptimizeRX relevé à 23$ contre 20$ par Citizens

OptimizeRX price target raised to $23 from $20 at Citizens